Novotech

News

Dubai Airports and GMR Announce the Formation of a Logistics Corridor for the Global Distribution of COVID-19 Vaccines

Dubai Airports, operator of Dubai International (DXB) and Dubai World Central (DWC), and GMR Hyderabad (GMR-HYD) have joined forces to create a Covid-19 vaccine distribution corridor. Home to 88 global airlines including Dubai's flagship carrier Emirates, and 12 international and...

Trane Technologies Thermo King offers cold chain solutions for transport and storage of COVID-19 vaccines in India

Thermo King, by Trane Technologies, a global climate innovator, has launched its expanded portfolio of cold chain solutions in India, which can keep vaccines at temperatures from a range of +25 degrees celsius to as low as -70 degrees...

Moderna Provides COVID-19 Vaccine Supply Update

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021. Moderna said it is...

Giant leap for innovation: Bharat Biotech after DCGI approval to Covaxin

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine --Covaxin -- is a giant leap for innovation and novel product development in India. The Hyderabad-based vaccine maker expressed its delight after Drug Controller General of...

Treating brain disorders with new nanoparticle drug delivery system

A new nanoparticle drug-delivery system could help scientists overcome the long-standing problem of delivering therapeutics across the blood-brain barrier and into the brain. Progress has been made over the past few decades in identifying biological pathways that lead to neurodegenerative...

Forge Biologics receives US FDA approval to initiate phase 1/2 trial of AAV gene therapy, FBX-101 to treat Krabbe disease

Forge Biologics Inc., a gene therapy manufacturing and development company, announced that the company has received FDA clearance of the Investigational New Drug (IND) to initiate a phase 1/2 clinical trial evaluating its novel, first-in-human AAV gene therapy, FBX-101,...

Pfizer, OPKO One Step Closer to Approval of Pediatric Growth Hormone Deficiency Drug

Pfizer and OPKO Health are one step closer to receiving approval for their jointly developed pediatric growth hormone deficiency (GHD) drug, somatrogon, after the U.S. FDA recently accepted the companiesโ€™ regulatory submission for the therapy. The FDA accepted for filing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป